In this episode, recorded live at BSR25, Professor Robert J Moots joins Professor Ernest Choy to discuss their article reporting on a randomized, controlled, head-to-head clinical trial comparing the two most frequently used biologics in active refractory Behçet’s. Listen now to hear the findings and what this means for future clinical practice! Further reading: You can read this article [https://doi.org/10.1093/rheumatology/keae585] in Rheumatology. Thanks for listening to T...
All content for Talking Rheumatology Research is the property of British Society for Rheumatology and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, recorded live at BSR25, Professor Robert J Moots joins Professor Ernest Choy to discuss their article reporting on a randomized, controlled, head-to-head clinical trial comparing the two most frequently used biologics in active refractory Behçet’s. Listen now to hear the findings and what this means for future clinical practice! Further reading: You can read this article [https://doi.org/10.1093/rheumatology/keae585] in Rheumatology. Thanks for listening to T...
Ep 37. Can MSUS and RADAI-F5 help to identify RA patients at risk of poor functional and radiological outcomes?
Talking Rheumatology Research
12 minutes
2 years ago
Ep 37. Can MSUS and RADAI-F5 help to identify RA patients at risk of poor functional and radiological outcomes?
Anika Hoque joins Dr Michael Backhouse to discuss their recent article, which examines the construct validity of the RA foot disease activity index in relationship to musculoskeletal ultrasonography and clinical examination.Listen now to hear the findings, and what this means for future clinical practice and the impact on RA patients at risk for poor functional and radiological outcomes.You can read this article [https://doi.org/10.1093/rap/rkad048] in Rheumatology Advances in Practice.Thanks...
Talking Rheumatology Research
In this episode, recorded live at BSR25, Professor Robert J Moots joins Professor Ernest Choy to discuss their article reporting on a randomized, controlled, head-to-head clinical trial comparing the two most frequently used biologics in active refractory Behçet’s. Listen now to hear the findings and what this means for future clinical practice! Further reading: You can read this article [https://doi.org/10.1093/rheumatology/keae585] in Rheumatology. Thanks for listening to T...
